Skip to main content
. 2022 Jan 19;3(3):477–487. doi: 10.34067/KID.0006672021

Figure 4.

Figure 4.

Network meta-analysis results of the effect of SGLT2is on blood phosphate levels. (A) Network of eligible comparisons for the multiple-SGLT2is meta-analysis for effects on blood phosphate levels. Each node represents one treatment. The directly compared treatments are linked with a solid line; the width of the lines is proportional to the number of randomized participants (sample size), and the size of every node is proportional to the number of trials comparing every pair of treatments. (B) Network meta-analysis combining direct and indirect evidence within a network of eligible trials for the effects of SGLT2is on blood phosphate levels (mmol/L). The black solid lines represent the CIs for WMD of blood magnesium levels for each comparison, and the blue line is the line of no effect (WMD=0).